| abstract |
The invention provides a crystal form of camostat mesylate, a hydrate crystal form of camostat mesylate, an acetone solvate crystal form of camostat mesylate, an N, N-dimethylformamide solvate crystal form of camostat mesylate, and preparation methods and applications of the crystal form and the hydrate crystal form of camostat mesylate. Wherein, the crystal form of the camostat mesylate and the hydrate crystal form thereof have good medicinal value. Therefore, the invention also provides the application of the crystal form or the hydrate crystal form in preparing a medicament for treating pancreatitis, reflux esophagitis and diseases caused by coronavirus infection. |